News

Egis is one of the most attractive workplaces in the pharma industry

2017.04.25.
Our company was awarded based on the evaluation of employees and job seekers. details >

Dr. Klára András will be HR Director of Egis Pharmaceuticals PLC

2017.03.29.
from April 1, 2017 details >

Egis strengthens presence in Russia by OTC acquisition

2017.02.06
Egis acquired Russian D-Panthenol and women’s health product portfolio from Jadran-Galenski Laboratorij’s (JGL). details >

Egis is investor of the month

2016.12.02.
The recognition, founded by the Minister of National Economy, is given the investors, SME-s and start-ups which have achieved outstanding results. In December 2016, Egis Pharmaceuticals was awarded “Investor of the month”. details >

Egis reports revenue from collaboration with Actavis

2016.11.14.
Egis Pharmaceuticals today announced that it has generated $110 million (USD) in revenue related to the collaboration and sale of generic rosuvastatin calcium by Actavis in the United States. details >

Egis launches major project

2016.10.28.
Egis and its consortium partners have received governmental and EU fund for the research and development of new products and for the establishment of a production unit at the company’s site in Körmend. details >

<<<12>>>